ScholarLens Back to search
2011•PEDIATRICSRequires access

Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema

Bradley E. Chipps

Open publisher page 18 citations

Abstract

BL Zuraw, PJ Busse, M White. N Engl J Med. 2010;363(6):513–522 To determine the efficacy of nanofiltered C1 inhibitor concentrate in the management of hereditary angioedema (HAE). Subjects were from 2 studies; the lowest age was 6 years (median age: 36 years). Both studies compared an intravenous dose of 1000 U of nanofiltered C1 inhibitor concentrate in the management of HAE. The first study end point was the time to unequivocal relief of symptoms during an acute attack of HAE. The second study was …

About this research paper

What this paper is about

BL Zuraw, PJ Busse, M White. N Engl J Med. 2010;363(6):513–522 To determine the efficacy of nanofiltered C1 inhibitor concentrate in the management of hereditary angioedema (HAE). Subjects were from 2 studies; the lowest age was 6 years (median age: 36 years). Both studies compared an intravenous dose of 1000 U of nanofiltered C1 inhibitor concentrate in the management of HAE. The first study end point was the time to unequivocal relief of symptoms during an acute attack of HAE. The second study was …

Why it matters

OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

BL Zuraw, PJ Busse, M White. N Engl J Med. 2010;363(6):513–522 To determine the efficacy of nanofiltered C1 inhibitor concentrate in the management of hereditary angioedema (HAE). Subjects were from 2 studies; the lowest age was 6 years (median age: 36 years). Both studies compared an intravenous dose of 1000 U of nanofiltered C1 inhibitor concentrate in the management of HAE. The first study end point was the time to unequivocal relief of symptoms during an acute attack of HAE. The second study was …

Key concepts: Hereditary angioedema, Medicine, C1-inhibitor, Angioedema, Dermatology, Internal medicine, Pediatrics, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema — Research Paper | ScholarLens